Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2025: 1.36

Amneal Pharmaceuticals, Inc. Interest Coverage Ratio is 1.36 for the Trailing 12 Months (TTM) ending June 30, 2025, a -2.46% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2024 was 1.39, a 5.70% change year over year.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2023 was 1.32, a -327.99% change year over year.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2022 was -0.58, a -143.49% change year over year.
  • Amneal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2021 was 1.33, a 190.74% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)